DNA probes display advantages including flexible design,wide range of targets and high selectivity,but free DNA probes are confined to in vitro detection due to their poor cell penetration and low nuclease resistance....DNA probes display advantages including flexible design,wide range of targets and high selectivity,but free DNA probes are confined to in vitro detection due to their poor cell penetration and low nuclease resistance.Nanomaterials-loaded DNA probes can effectively solve above limitations and promote them in vivo applications.Gold nanoparticles-based probes have been intensely investigated in the past,and AuNP@DNA nanoflare as one of the most powerful tools for biomedical study has been developed.So far,towards Au NP@DNA nanoflare,significant advances in preparation(e.g.,salt-aging,low pH-assisted and freezing-directed linking)and application(e.g.,sensing and therapeutic nanoflares)have been achieved since first report.In addition,scientific challenges involved in AuNP@DNA nanoflares have been concerned and some endeavor has been made recently.Here,a historical review is provided for AuNP@DNA nanoflares:methodology in preparation and applications in bioanalysis and biomedicine are delineated,challenges and outlook are also discussed,which are expected to improve the further development of this fertile research area.展开更多
Immunoassay technology is an analytical method with high sensitivity and specificity; it provides a technique to assay materials which cannot be measured by other methods, or are difficult to detect. It plays a very i...Immunoassay technology is an analytical method with high sensitivity and specificity; it provides a technique to assay materials which cannot be measured by other methods, or are difficult to detect. It plays a very important role in biological sample pre-treatment, therapeutic drug monitoring and drug determination, and is one of the important means for in vivo drug analyses. This paper reviews immunoassays commonly used in bioanalysis, including immunoextraction and immunodepletion for pretreatment of biological samples, conventional immunoassay methods and new immunoassay technologies for determination of target drugs.展开更多
Significant investment in nanocarrier drug delivery systems(Nano-DDSs)has yielded only a limited number of successfully marketed nanomedicines,highlighting a low rate of clinical translation.A primary contributing fac...Significant investment in nanocarrier drug delivery systems(Nano-DDSs)has yielded only a limited number of successfully marketed nanomedicines,highlighting a low rate of clinical translation.A primary contributing factor is the lack of foundational understanding of in vivo processes.Comprehensive knowledge of the pharmacokinetics of Nano-DDSs is essential for developing more efficacious nanomedicines and accurately evaluating their safety and associated risks.However,the complexity of Nano-DDSs has impeded thorough and systematic pharmacokinetic studies.Key components of pharmacokinetic investigations on Nano-DDSs include the analysis of the released drug,the encapsulated drug,and the nanomaterial,which present a higher level of complexity compared to traditional small-molecule drugs.Establishing an appropriate approach for monitoring the pharmacokinetics of Nano-DDSs is crucial for facilitating the clinical translation of nanomedicines.This review provides an overview of advanced bioanalytical methodologies employed in studying the pharmacokinetics of anticancer organic Nano-DDSs over the past five years.We hope that this review will enhance the understanding of the pharmacokinetics of Nano-DDSs and support the advancement of nanomedicines.展开更多
基金supported in part by the financial support through the National Natural Science Foundation of China(Nos.22074008,22222402,22207098)Natural Science Foundation of Hunan Province(No.2024J13001)+1 种基金the Aid Program for Science and Technology Innovative Research Team in Higher Educational Institutions of Huan Province(No.2023ct01)The Special Fund for Zaozhuang Talent Agglomeration Project。
文摘DNA probes display advantages including flexible design,wide range of targets and high selectivity,but free DNA probes are confined to in vitro detection due to their poor cell penetration and low nuclease resistance.Nanomaterials-loaded DNA probes can effectively solve above limitations and promote them in vivo applications.Gold nanoparticles-based probes have been intensely investigated in the past,and AuNP@DNA nanoflare as one of the most powerful tools for biomedical study has been developed.So far,towards Au NP@DNA nanoflare,significant advances in preparation(e.g.,salt-aging,low pH-assisted and freezing-directed linking)and application(e.g.,sensing and therapeutic nanoflares)have been achieved since first report.In addition,scientific challenges involved in AuNP@DNA nanoflares have been concerned and some endeavor has been made recently.Here,a historical review is provided for AuNP@DNA nanoflares:methodology in preparation and applications in bioanalysis and biomedicine are delineated,challenges and outlook are also discussed,which are expected to improve the further development of this fertile research area.
基金National Natural Science Foundation of China(Gr ant No.81102499)Hunan Science and Technology Project(Grant No.2011SK3261)
文摘Immunoassay technology is an analytical method with high sensitivity and specificity; it provides a technique to assay materials which cannot be measured by other methods, or are difficult to detect. It plays a very important role in biological sample pre-treatment, therapeutic drug monitoring and drug determination, and is one of the important means for in vivo drug analyses. This paper reviews immunoassays commonly used in bioanalysis, including immunoextraction and immunodepletion for pretreatment of biological samples, conventional immunoassay methods and new immunoassay technologies for determination of target drugs.
基金supported by the National Natural Science Foundation of China(Grant Nos.:82304443,82030107,and 82373944).
文摘Significant investment in nanocarrier drug delivery systems(Nano-DDSs)has yielded only a limited number of successfully marketed nanomedicines,highlighting a low rate of clinical translation.A primary contributing factor is the lack of foundational understanding of in vivo processes.Comprehensive knowledge of the pharmacokinetics of Nano-DDSs is essential for developing more efficacious nanomedicines and accurately evaluating their safety and associated risks.However,the complexity of Nano-DDSs has impeded thorough and systematic pharmacokinetic studies.Key components of pharmacokinetic investigations on Nano-DDSs include the analysis of the released drug,the encapsulated drug,and the nanomaterial,which present a higher level of complexity compared to traditional small-molecule drugs.Establishing an appropriate approach for monitoring the pharmacokinetics of Nano-DDSs is crucial for facilitating the clinical translation of nanomedicines.This review provides an overview of advanced bioanalytical methodologies employed in studying the pharmacokinetics of anticancer organic Nano-DDSs over the past five years.We hope that this review will enhance the understanding of the pharmacokinetics of Nano-DDSs and support the advancement of nanomedicines.
